Pages

Showing posts with label Heart attack Treatment. Show all posts
Showing posts with label Heart attack Treatment. Show all posts

Sunday, 8 May 2016

Aspirin Guidelines: Some Should Take It to Prevent Heart Attack

APR 12 2016,
Many adults who have never had a heart attack or stroke should take aspirin every day to keep it that way, new U.S. guidelines say.
People in their 50s with risk factors for cardiovascular disease - including high blood pressure, high cholesterol or a history of smoking - may benefit from starting a daily aspirin for at least a decade, according to the U.S. Preventive Services Task Force (USPSTF), a government-backed panel of independent physicians.

Image: aspirin

Featurepics

A daily low-dose aspirin may also help protect against colon cancer in people who are taking it to prevent heart attacks and strokes.
Because aspirin can cause bleeding in the stomach and brain, this advice doesn't apply to people with bleeding disorders.
"As with any drug, patients and their doctors must balance the benefits and risks of aspirin," said USPSTF chair Dr. Kirsten Bibbins-Domingo of the University of California, San Francisco.
Adults aged 50 to 59 who have at least a 10 percent risk of having a heart attack or stroke in the next decade can benefit the most from taking 81 milligrams of aspirin a day, according to the new guidelines.
The American College of Cardiology provides an online risk calculator here:bit.ly/1UEFYtE.
The advice doesn't apply to people in their 60s because the bleeding risk increases with age, however, and the jury is still out on whether this approach makes sense for people under 50 or over 70, the Task Force concluded.
"Some people may benefit from aspirin more than others, which is why there are several recommendations based on age," Bibbins-Domino added by email. The Task Force encourages people to talk with their doctor about whether taking aspirin is appropriate, she said.
Nearly 40 percent of U.S. adults over 50 already take aspirin to prevent a first heart attack or avoid a second one, according a research review published with the new guidelines in Annals of Internal Medicine.
But the Task Force is at odds with the U.S. Food and Drug Administration, which has denied efforts by Bayer HealthCare LLC to market aspirin for preventing heart attacks and strokes in people with no history of cardiovascular disease.
"All that aspirin does if your heart attack risk is really low is cause you harm," said Dr. Steven Nissen, who served on an FDA advisory panel that recommended against widespread use of aspirin for primary prevention and chairs the department of cardiovascular medicine at the Cleveland Clinic in Ohio.
At least one in 10 people taking aspirin don't need it, recent research suggests.
Patients can buy aspirin without a prescription, and doctors are also free to put people on medicines for purposes that aren't approved by the FDA.
The FDA did not immediately respond to a request for comment.
Aspirin helps prevent blood cells called platelets from sticking together and clogging arteries, leading to heart attacks and strokes. The drug carries a bleeding risk because the body also relies on platelet clusters to seal wounds by forming scabs.
Additionally, aspirin might lower the risk of colorectal cancer by acting on a biochemical pathway these tumors need to grow, said Dr. David Weinberg, chair of the department of medicine at Fox Chase Cancer Center in Philadelphia.
But patients shouldn't take aspirin for cancer prevention, Weinberg, who isn't on the Task Force, said by email. Instead, they should think of the reduced cancer risk as an added benefit if they already need aspirin to address the risk of heart attacks and strokes.
"For those persons already at higher risk for cardiovascular disease, on balance aspirin is a good idea to reduce cardiovascular disease risk alone," Weinberg said. "However, it appears it will also reduce colorectal cancer risk at the same time, which represents a benefit with little or no additional risk if aspirin is already indicated." 

Thursday, 7 April 2016

Cell therapy could help slow decline in heart failure patients, study suggests

(CNN)The odds of surviving a heart attack are better than ever in the United States thanks to improvements in therapies.
But that means about 2.5 million Americans live with heart failure that blocks blood vessels and reduces blood supply to the body.
<a href="http://www.cnn.com/2015/05/29/health/why-you-quit-smoking/">Break the addiction</a> for your cardiovascular health, for personal hygiene and your wallet. 86% of Americans met American Heart Association's ideal score for overall cardiovascular health, as of 2010, according to a <a href="http://www.abstractsonline.com/pp8/#!/3795/presentation/43327" target="_blank">recent study.</a>)

Updated 1710 GMT (0010 HKT) April 4, 2016


A new study provides an early indication that cell therapy using cells from bone marrow could one day help treat heart failure.
Researchers gave 60 patients with heart failure an injection of the therapy in the heart and compared their rates of death and heart problems to those of 66 similar patients who received a placebo injection of saltwater in the heart.
The researchers found that, during the year following the treatment, the patients who received the cell therapy had a 37% lower rate of death and hospitalization for heart failure-related problems, such as fluid buildup in the body or shortness of breath, compared with the placebo group. In the cell therapy group, 3.4% of the patients died and 51.7% were hospitalized for heart problems, whereas 13.7% of the placebo group died and 82.4% were hospitalized.
    "This would be considered a huge success because this much of a reduction has not been shown with any other (cell) therapy," said Dr. Amit N. Patel, director of the clinical regenerative medicine program in the University of Utah Department of Surgery.
    The therapy is working probably because it either "slows down or reverses the rate of progression of disease," said Patel, who led the clinical study, which was published on Monday in the journal The Lancetand presented at the annual scientific meeting of the American College of Cardiology. Rather than increasing the number of muscle cells or blood vessels in the heart, the therapy is probably making the muscle cells work better, he added.
    The company that developed the cell therapy technology, called Vericel Corp., funded and was involved in the study, although Patel said he had the final say about what was included in the article.
    Here's how the therapy, which is called Ixmyelocel-T, is carried out: The researchers remove about three tablespoons of bone marrow from the hip bone while the patient is lightly sedated. The cells in the bone marrow then grow in an instrument called a bioreactor for two weeks, producing a "soup" of cells containing certain types of stem cells and immune cells that can help remodel tissue and reduce inflammation, Patel said. Finally the researchers use special catheters to identify the weakest parts of the heart and inject the soup into these areas.
    In the year after the injection, 20.3% of the patients in the cell therapy group experienced an adverse event such as infection or stroke, compared with 41.8% of the placebo group. "It was surprising that the (placebo) patients did significantly worse," Patel said. This could have been because they underwent the same invasive procedures as the treatment group, but did not receive the same potentially beneficial cell therapy, which could have anti-inflammatory effects that decreased adverse events, he said.
    "The study is very exciting because for the first time it showed a physical impact on clinical events, and in this case that was mortality and rehospitalization for heart failure," said Dr. Thomas J. Povsic, an interventional cardiologist and associate professor of the Duke Clinical Research Institute. Povsic was not involved in the study, but wrote an editorial about the study for the same issue of The Lancet.
    Nevertheless, this therapy will need to be tested on more patients, Povsic said. "Although the study in The Lancet is very encouraging, it's still a relatively small study by cardiovascular standards. In heart disease we typically study hundreds to thousands of patients," he said.
    The researchers and Vericel are hoping to start a larger phase 3 clinical trial of Ixmyelocel-T that includes more heart failure patients. The new study was a phase 2 trial, and these trials generally focus on establishing the effectiveness and safety of a new therapy.
    There are currently several phase 2 and 3 trials underway testing cell therapies for the treatment of various types of heart disease. So far, studies have either not addressed the therapy's effect on clinical outcomes, or failed to observe an improvement in heart disease.
    Earlier cell therapies used all the cells in the bone marrow instead of selecting for certain types of cells, and thus might have been diluting their beneficial effects, Povsic said. "We are moving more and more away from first generation cell therapy," said Povsic, who is involved in two ongoing trials looking at the effect of selected cells from bone marrow in patients with heart failure or angina, a type of heart disease that reduces blood supply to the heart.
    No cell therapies have been approved worldwide for heart failure patients. There are also no approved cell therapies for other types of heart disease in the United States, but several therapies are available in Asia, including a stem cell-based treatment for people who have had a heart attack.
    The therapy in the new study would be appropriate for patients who have heart failure and are getting worse, despite taking medicines such as beta blockers and ACE inhibitors, Patel said. Nearly all the patients in the study were on one of these drugs. However, the therapy would not be appropriate for patients whose heart failure is so bad that they are often hospitalized for heart complications, Patel said. These patients would be candidates for a heart transplant or left ventricular assist device.
    "There's a growing population of (heart failure) patients that are on medicines and who continue to have significant symptoms," Povsic said.

    http://edition.cnn.com/2016/04/04/health/heart-failure-cell-therapy/index.html

    Sunday, 10 May 2015

    More aspirin, more often, less cancer?

    Standard medicine is really after you to take as many of their drugs as you can handle for as long as you can possibly take them. And they’ll play on your fears to get the job done.



    Two aspirin pillsTake the newest analysis claiming aspirin prevents cancer that’s all over the news. Researchers looked at data on 82,600 women enrolled in the famous Nurses’ Health Study in 1980 and 47,650 men from in the Health Professionals Follow-up Study in 1986. They collected data on aspirin use, risk factors for cancer and diagnoses of cancer.
    After up to 32 years of follow-up, about 20,400 women and 7,570 men developed cancer, the investigators found. But those who took a 325 mg dose of the pain-relieving drug – yes, it’s a synthetic drug – two times a week or more had a lower risk of gastrointestinal cancers than people who did not regularly take aspirin.
    About 50 million Americans take a daily dose of aspirin, so are they safer from cancer than people who don’t? Well, the analysis was done at Harvard, so it must be right … right?
    Not exactly. This survey could show many things depending on how you interpret it and what you’re looking for. Maybe all this survey shows is that people who are not technically considered at high risk for cancer are also deciding to use aspirin and are not getting cancer but probably wouldn’t have anyway. We just don’t know.
    Also, did you know there’s a serious trade-off in taking aspirin every day, even if you restrict yourself to a child’s aspirin that’s only 81 mg?
    Aspirin significantly thins the blood and can cause internal bleeding, including brain bleeding, at any dose. I don’t know about you but that doesn’t sound good to me. The Food and Drug Administration (FDA) warns that for every person who may be saved by aspirin from a first heart attack or stroke, somebody else is victimized by significant gastrointestinal bleeding that, if allowed to go on too long, can prove fatal.
    survey by the University of Oregon of Americans ages 45 to 75, shows that 52 percent of people in this age group use aspirin and another 21 percent had used it in the past. Other studies have shown that aspirin use grew by at least 57 percent in the past decade.
    Currently, the FDA thinks that a daily small dose of aspirin is worthwhile for people who have already had a heart attack or stroke. “There’s no doubt that aspirin use can have value for people who have experienced a first heart attack, stroke or angina,” says researcher Craig Williams. “The data to support that is very strong. The support of its use in primary prevention (for people who have not experienced cardiovascular problems) is more of a mixed bag.”
    So even if your doctor recommends aspirin, consider your options carefully. You’re better off leading a heart-healthy lifestyle with a good diet and plenty of exercise than popping a pill that can cause internal bleeding. Even the FDA warns against taking aspirin as a “just in case” measure to ward off heart problems. Plus, as Dr. Michael Cutler tells me, there are plenty of natural ways to keep your heart healthy that don’t involve drugs.
    http://easyhealthoptions.com/aspirin-often-less-cancer/

    Go to Healthwise for more articles

    Wednesday, 6 August 2014

    FDA Reverses Its Position on Daily Aspirin

    August 04, 2014 
    Aspirin Dosage

    Story at-a-glance

    • The FDA recently reversed its position on taking daily aspirin if you haven’t had a heart attack, concluding that the risks outweigh the benefits
    • Scientific studies have failed to prove that low-dose aspirin offers safe and effective protection from cardiovascular disease
    • Aspirin can lead to serious medical problems such as gastrointestinal and intracranial bleeds, ulcers, kidney failure, blindness, and many more
    • A safer, more effective approach to heart health is reducing chronic inflammation through diet, exercise, sun exposure, and grounding yourself to the earth
    By Dr. Mercola
    If you haven't had a heart attack, step away from the aspirin bottle... If you are one of the 40 million Americans who take an aspirin every day, you may want to heed the latest warning from the US Food and Drug Administration (FDA).
    After many decades of promoting aspirin, the FDA now says that if you have not experienced a heart problem, you should not be taking a daily aspirin—even if you have a family history of heart disease. This represents a significant departure from FDA's prior position on aspirin for the prevention of heart attacks.
    On its website, the FDA now says:12
    "FDA has concluded that the data do not support the use of aspirin as a preventive medication by people who have not had a heart attack, stroke or cardiovascular problems, a use that is called 'primary prevention.' In such people, the benefit has not been established but risks — such as dangerous bleeding into the brain or stomach — are still present."
    Their announcement was prompted by Bayer's request to change its aspirin label to indicate it can help prevent heart attacks in healthy individuals. Aspirin generated $1.27 billion in sales for Bayer last year,3 and from Bayer's request, it appears they want everyone to be taking their drug.
    But the FDA says "not so fast"—and rightly so. Evidence in support of using aspirin preventatively has gone from weak to weaker to nonexistent. This is why I've been advising against it for more than a decade. It looks as though aspirin, even "low-dose aspirin" (LDA), may do far more harm than good.
    In fact, it is debatable whether or not aspirin has ANY protective benefits against cardiovascular disease, even if you have suffered a heart attack or stroke. Recent scientific studies have uncovered a number of serious side effects, suggesting that whatever aspirin may offer may be overshadowed by its risks, especially when safer natural alternatives exist.
    As is true for nearly all medications, the longer we watch for side effects, the more we tend to find—even for drugs like aspirin that have been around for more than 100 years. Just because aspirin is an over-the-counter drug and has been around for more than a century does not mean that it's harmless.

    Aspirin May Conceal a Cardiac Event in Progress

    Roughly 800,000 Americans die from cardiovascular disease annually, which includes heart attacks and stroke. This is why heart health has been such a major focus, and why aspirin was hailed as a "wonder drug" by those who believed it was a safe and effective preventative. But that ship has sailed.
    Nearly 10 years ago, Dr. John G. F. Cleland, a cardiologist from the University of Hull in the UK, wrote an excellent article published in the British Journal of Medicine4 casting doubt upon the efficacy of aspirin therapy for prevention of heart attacks.
    Based on a series of meta-analyses from the Antithrombotic Trialists' Collaboration,5 which is an enormous body of research following more than 100,000 patients at high risk for cardiac events, Dr. Cleland concluded that aspirin therapy was not saving lives. Rather, aspirin seems to change the way vascular events present themselves.
    The number of non-fatal events may be reduced, but the number of sudden deaths is actually increased, because what most physicians don't realize is that surprisingly aspirin can mask a cardiac event in progress.
    Dr. Cleland also found that studies touting aspirin's benefits are seriously flawed and interpretation of those studies is biased. Since Cleland's original study, a deluge of scientific studies have further exposed aspirin's failure, which I have summarized in the next few sections.

    Studies Show Aspirin Is a Dismal Failure at Preventing Heart Attacks

    The following table lists, chronologically, a sampling of studies showing that taking aspirin may do more harm than good. Regardless of whether you're a man, woman, or diabetic, aspirin has failed miserably. This list of studies is not comprehensive. You will find much more information in the GreenMedInfo database, which lists more than 60 articles about aspirin's toxic effects.6
    StudySignificant Cardiovascular Findings
    American Heart Journal 2004 (WASH)Patients receiving aspirin treatment showed the worst cardiac outcomes, especially heart failure
    New England Journal of Medicine20057Ten-year study at Harvard involving nearly 40,000 women found no fewer heart attacks or cardiovascular deaths among women receiving aspirin therapy
    British Medical Journal 20098Aspirin therapy for diabetics produced no benefit in preventing cardiovascular events
    Pharmacoepidemiological Drug Safety 20099Swedish researchers studying individuals with diabetes found no clear benefit for aspirin, but did note it can increase the risk of serious bleeding
    Journal of the American Medical Association 201010, 11Scottish study found that aspirin did not help prevent heart attacks or strokes in healthy, asymptomatic individuals with a high risk of heart disease
    Journal of the American College of Cardiology 201012Patients taking aspirin showed a higher risk for recurrent heart attack and associated heart problems
    Expert Opinions in Pharmacotherapy 201013British meta-analysis of 7374 diabetics concluded that aspirin does not lower heart attack risk

    Aspirin Increases Your Risk of Bleeding

    Not only has aspirin failed to reduce the prevalence of heart attacks and strokes, but the list of its adverse effects seems to grow greater the more that it is studied. Chief among these is gastrointestinal bleeding, as aspirin interferes with your platelets—the blood cells that allow your blood to clot. According to one article, long-term low-dose aspirin therapy may double your risk for a gastrointestinal bleed.14
    Aspirin also increases your risk for a brain bleed, especially if you are older. One study found a high mortality rate for elderly individuals who had been taking aspirin prophylactically when they suffered a head trauma, resulting in deadly brain hemorrhage.15

    Aspirin Destroys the Lining of Your Gastrointestinal Tract

    Regular aspirin use also destroys the lining of your gastrointestinal tract, increasing your risk for duodenal ulcers, H. Pylori infection,16 Crohn's disease,17diverticular disease, inflammatory bowel disease (IBD), and intestinal perforations. More than 10 percent of patients taking low-dose aspirin develop gastric ulcers. The damage to your duodenum—the highest part of your intestine into which your stomach contents pass—can result in duodenal ulcers, which are prone to bleeding. Even low-dose aspirin is proven to cause problems.
    A Japanese study found a higher incidence of bleeding at the ulcer sites of patients with duodenal ulcers taking low-dose aspirin (LDA) therapy, versus those not taking LDA.18 An Australian study also showed that aspirin causes gastroduodenal damage even at the low doses used for cardiovascular protection (80mg).19 And Japanese researchers found that aspirin had caused "small bowel injuries" to 80 percent of study participants after only two weeks of aspirin therapy.20

    Even MORE Bad News for Bayer

    Each year, 15,000 people die and 100,000 people are hospitalized as the result of aspirin and other NSAIDs—and these are probably conservative estimates. But aspirin may be one of the oldest killer drugs! Strong historical evidence points to aspirin overdose as a major contributor to high death tolls during the 1918 influenza pandemic. Aspirin toxicity can result in hemorrhage and fluid buildup in your lungs, which can result in death. If you are interested in the evidence for this, please read Dr. Karen Starko's fascinating paper in Clinical Infectious Diseases.21
    Lending even more weight to Starko's work, an animal study in 2010 suggests that treating the flu with antipyretics (such as aspirin) may increase your risk of death. This study involved animals, but the results were compelling enough for the researchers to make an "urgent call" for human studies.22 Aspirin also depletes your body of important nutrients, including vitamin C, vitamin E, folic acid, iron, potassium, sodium, and zinc,23 as well as impairing your melatonin production.24 And in addition to aspirin's growing list of bodily assaults, routine aspirin use has been associated with even broader health problems, such as:
    • Increased risk of one type of breast cancer in women (ER/PR-negative)25
    • Increased risk of kidney failure
    • Cataractsmacular degeneration, and blindness26
    • Hearing loss27 and tinnitus28
    • Erectile dysfunction: Aspirin and other NSAIDs have been linked to a 22 percent increase in your risk of erectile dysfunction (ED), according to Kaiser researchers who studied more than 80,000 men29

    The Real Key to Protecting Your Heart Is Reducing Chronic Inflammation

    Getting back to the subject of your heart, with all of these adverse effects, why risk taking aspirin when there are safer and more effective alternatives? About one in three deaths in the US are attributed to cardiovascular disease—but 25 percent of those are preventable.
    The key is to address chronic inflammation, which can be accomplished by making specific lifestyle changes that encompass diet, exercise, sun exposure, and bare skin contact with the earth. In the remainder of this article, I will focus on heart-health strategies that work FAR better than aspirin. For additional information, please refer to our prior article about cardiovascular disease.

    Heart Health Tip #1: Adopt a TRULY Heart-Healthy Diet

    My "heart-healthy diet" is vastly different from what government regulators and most conventional cardiologists recommend—because mine is actually based on science. The following table summarizes my basic nutritional recommendations, all of which will help quell chronic inflammation. For further guidance about how to proceed with your diet, I suggest reviewing myOptimized Nutrition Plan.
    Limit or eliminate all processed foods and genetically modified foods (GMOs)
    Eliminate all gluten and highly allergenic, pro-inflammatory foods
    Swap all trans fats (vegetable oils, margarine, etc.) for healthy fats like avocado, raw butter, nuts, seeds, and coconut oil
    Eat at least one-third of your food raw, or as much as you can manage
    Increase the amount of fresh vegetables in your diet
    Consume naturally fermented foods every day, which improves microbial diversity in your gut and helps keep chronic inflammation at a minimum
    Avoid artificial sweeteners of any kind
    Limit dietary sugar, especially processed fructose. Restrict your fructose to less than 25 grams per day, from all sources, including whole fruits. If you have insulin resistance, diabetes, hypertension, or heart disease, you'd be well advised to keep your fructose below 15 grams per day
    Eat organic foods whenever possible to avoid exposure to harmful agricultural chemicals, such as glyphosate
    To rebalance your omega-3 to omega-6 ratio, take a high-quality omega-3 supplement, such as krill oil, and reduce your consumption of processed vegetable oils, which are high in poor-quality omega-6 fats and trans fats
    Drink plenty of clean, pure water

    Heart-Health Tip #2: Avoiding Trans Fat Is ESSENTIAL



    Aspirin was thought to provide its protective action by inhibiting cyclooxygenase and thus favorably modulating inflammatory prostaglandins, which essentially decrease platelet formation and thus "thins the blood." However there are far more effective ways to favorably influence this pathway. I recently interviewed Dr. Fred Kummerow who is nearly 100 years old and was the first scientist to document the dangers of trans fats. If you haven't watched the video yet, I would strongly encourage you to do so.
    In the interview Dr. Kummerow explains that trans-fats prevent the formation of prostacyclin that thins your blood. By diligently avoiding all trans-fats, your body will happily make prostacyclin and keep your blood thin so you avoid heart attacks and strokes. Avoiding trans fats is imperative for your cardiovascular health. This is a FAR more effective strategy than eating trans-fats and taking aspirin to thin your blood.

    Heart Health Tip #3: Exercise and Change Your Eating Schedule

    One of the primary benefits of exercise is that it helps optimize your insulin and leptin levels. Following the dietary guidelines above will move you closer to the mark, but adding exercise can bring you across the finish line. A sizable study published inThe Lancet found that a mere 15 minutes of exercise per day can add three years to your life—even if you have cardiovascular disease risks.30
    If your fasting insulin level is above three, seriously consider restricting your intake of grains and sugars until your insulin level is three or below (in terms of fructose, aim for a maximum of 15 grams per day). You might want to incorporate intermittent fasting into your diet and exercise plan, which can accelerate your progress. Intermittent fasting increases insulin/leptin sensitivity and mitochondrial efficiency, reduces oxidative stress, boosts growth hormone production, and helps you shed excess body fat. This is important as insulin and leptin resistance are at the core of most all cardiovascular diseases.

    Heart Health Tip #4: Improve Your Blood Viscosity by Grounding Yourself to the Earth


    Earthing may actually be one of the best-kept secrets for preventing blood clots—it's an old practice gaining a new appreciation! In the simplest terms, Earthing (or grounding your body to the earth) is what occurs when you walk barefoot on bare soil, grass, sand, brick, etc. Free electrons are transferred from the earth into your body through your feet, and these electrons are some of the most potent antioxidants known to man.
    One of the most important discoveries about Earthing is that it makes your blood less viscous, which has profound implications for your cardiovascular health because virtually every aspect of cardiovascular disease has been correlated with elevated blood viscosity. Earthing is so effective at achieving a blood thinning effect that anyone take prescription anticoagulants like Coumadin need to lower their dosage if they start to implement Earthing.
    When you ground, your red blood cells have more charge on their surface, which forces them to repel each other, so they have less tendency to "stick together" and form a clot. This causes your blood to flow more easily and your blood pressure to drop. Even a very small blood clot can kill you if it lodges in a critical area of your body, so this "blood thinning" has profound health benefits. Research shows that it takes about 80 minutes for the free electrons from the earth to reach your blood stream and transform your blood. One warning: if you take Coumadin, Earthing is contraindicated as it may thin your blood too much.
    By implementing many of the strategies outlined above, you will make far greater progress than relying on drugs such as aspirin, which nearly always come with adverse effects. Remember, heart attacks are not caused by an aspirin deficiency, as some would have you believe!
    [+] Sources and References

    http://articles.mercola.com/sites/articles/archive/2014/08/04/daily-aspirin-side-effects.aspx